n-methylisoindigotin has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Liu, JJ; Ma, N; Mu, YL; Shentu, LM; Sun, Y; Wang, LY; Wang, Y; Zhang, GM | 1 |
1 other study(ies) available for n-methylisoindigotin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Inhibition of NF-κB and Wnt/β-catenin/GSK3β Signaling Pathways Ameliorates Cardiomyocyte Hypertrophy and Fibrosis in Streptozotocin (STZ)-induced Type 1 Diabetic Rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Lipid Metabolism; Male; Myocytes, Cardiac; NF-kappa B; Pyrrolidines; Rats; Streptozocin; Thiocarbamates; Wnt Signaling Pathway | 2020 |